跳至主要内容
临床试验/ACTRN12624000262505
ACTRN12624000262505尚未招募1 期

Feasibility of prebiotic fibre supplementation during allogeneic stem cell transplantation, a pilot randomised control trial

Metro North Hospital and Health Service0 个研究点目标入组 36 人开始时间: 2024年3月15日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged 18 or older undergoing allogeneic myeloablative or reduced intensity myeloablative allogeneic stem cell transplantation at the Royal Brisbane and Women’s Hospital (RBWH).

排除标准

  • inflammatory bowel disease
  • formal diagnosis of irritable bowel syndrome
  • gastrointestinal resection
  • ileostomy or colostomy
  • any bariatric surgery including gastric bypass surgery, sleeve gastrectomy and gastric
  • any other contraindication to a high fibre diet (e.g. active diverticulitis or bowel
  • obstruction)
  • allergy/ intolerance to any ingredient in the fibre supplement or enteral feed
  • current and planned ongoing consumption of probiotic or prebiotic supplements
  • hepatitis B, hepatitis C or HIV infection unless viral load negative
  • participation in a GVHD prevention trial during SCT
  • on carbamazepine
  • inability to provide written informed consent

研究者

相似试验